Tom Taulli

Tom Taulli

Expertise: Artificial intelligence, cloud computing, cybersecurity

Education: BA, Cal Poly Pomona; JD, Whittier Law School

Awards & Accomplishments: IRS Enrolled Agent; California insurance license

Tom Taulli is the author of various books. They include Artificial Intelligence Basics and the Robotic Process Automation Handbook. His upcoming book is called Generative AI: How ChatGPT and other AI Tools Will Revolutionize Business.

Besides his writing, Tom has authored courses for PluralSight, Apress and O’Reilly Publishing. And yes, they are about topics like AI and cloud computing.

Tom currently advises various early stage companies about AI. He also is an angel investor.

Before this, Tom founded tech companies like ExamWeb, WebIPO and Hypermart, which was sold to InfoSpace.

Recent Articles

Why Amarin Stock Is Poised for a Healthy 2020

During the past year, Amarin stock has been a laggard. But this could change in 2020 with the company's new drug poised for long-term growth.

What Investors Need to Know About the Casper IPO

One of the more interesting stories in finance to start 2020 is the Casper IPO. With that being said, here's a deeper look at their filing.

3 Reasons AMD Stock Looks Very Stretched Right Now

AMD has ended the year at a blistering pace. But investors should be wary. The shares may be vulnerable for a reversal.

The Growth Buzz for Luckin Stock Is Far from Over

The latest quarter from Luckin was simply amazing. Growth is going at gangbusters. And don’t expect this to end any time soon.

Has the Smoke Finally Cleared for Canopy Growth Stock?

Cannabis investors will certainly want to forget 2019. In fact, the new year is shaping up to be much better, at least for the top-tier operators like Canopy Growth.

It’s Time to Be Cautious With General Electric Stock

GE stock has ended the year on a strong note. But the rally may be running out of gas, as the company still faces some tough challenges

Nio Stock Price Rallies but Don’t Expect It to Last

At the end of the year, there was a strong bull move in Nio stock, but don’t expect it to last. Here’s a look at some of the issues with the company.

The Diagnosis for Teva Stock Still Looks Grim

Lately, Teva stock has had a nice rally, but this may prove temporary. The fact is that the company faces much uncertainty with the litigation.

Everything You Need to Know About Stock Buybacks

Buying back stock has permeated Wall Street culture since the eighties, making it a crucial keystone to understanding share repurchases and how they work.

3 Reasons Why the Mega Rally of Snap Stock May Be Over

2019 was a great year for Snapchat stock. But the momentum of SNAP stock could slow down. Here’s a look at three reasons why.